SOURCE: Milestone Scientific, Inc.

March 10, 2014 07:30 ET

Milestone Scientific Anticipates Significant Increase in Wand® Handpiece Sales in Second Half of 2014

LIVINGSTON, NJ--(Marketwired - March 10, 2014) -   Milestone Scientific Inc. (OTCQB: MLSS), a leading medical research and development company that designs and patents innovative injection technology, today announced that Aseptico, its exclusive dental distributor, will now only sell Milestone's STA Wand® handpieces directly to dentists and will no longer sell through third-party distributors. As a result, the Company announced that it anticipates increased Wand® handpiece sales in the second half of 2014 due to the greater transparency and direct contact it will have with dentists through Aseptico.

Glenn Kazen, President of Aseptico, stated, "We have experienced increased demand for Milestone's Wand STA system and we continue to receive positive feedback from our customers. We look forward to providing our new and existing dental customers with exclusive access to the most advanced drug delivery system on the market."

Leonard Osser, Chief Executive Officer of Milestone Scientific, commented, "We are very pleased to continue our successful distribution relationship with Aseptico. Now that Aseptico will only sell the STA Wand handpieces directly to dentists, we will have greater transparency with our customers. Aseptico shares with us the names of all the dentists that use our instruments. By capturing that information, we are able to establish a direct relationship with the dentists and provide them a training program through our in-house education staff as well as our hygienists in the field to ensure that they are fully utilizing all functions of the instruments and the disposables. We know from experience that once we train dentists, they utilize a greater number of handpieces each year."

Mr. Osser continued, "As a result of this expanded distribution agreement and the increased transparency with dentists, we anticipate seeing an increase in handpiece sales in the third and fourth quarters of this year as our former handpiece distributors sell through their remaining inventory."

About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website:

About Aseptico Inc.
Headquartered in Woodinville, Washington, Aseptico is a leading designer and manufacturer of surgical, endodontic, and portable dental equipment that is distributed worldwide. Aseptico manufactures products in the United States and employs over 100 local staff at the Company's headquarters in the greater Seattle area. Aseptico has an in-house engineering team and develops products to be fully regulatory compliant to US and international manufacturing and safety standards, including FDA Good Manufacturing Practices, ISO 60601-1, and ISO 13485:2003. Aseptico also exports its products to over 125 countries. Additional information is available at:

Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2012. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contact Information

  • Contact:
    David Waldman or Natalya Rudman
    Crescendo Communications, LLC
    Tel: 212-671-1020